| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64d1f9c01a928d73d5b14758b7cd12c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_449f4de1ca8d99d81978a31e62e524ed |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-021 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-275 |
| filingDate |
2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a20bb6dbffcc14cf970233027ff8621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_684604bbf3f1cf04c2159d45efb6dd41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1805d9ba69ec98c9b90813551a1c0a97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b42d90729a814fd16deca384254c0531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84b29f5c83343f62a14935e0af33797a |
| publicationDate |
2007-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1496939-B1 |
| titleOfInvention |
Modified cea nucleic acid and expression vectors |
| abstract |
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid. |
| priorityDate |
2002-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |